ABSTRACT
INTRODUCTION
The ability to specifically control the expression of a cloned gene in a homogeneous population of stably transfected cells provides a powerful tool for studying protein function. Inducible expression systems permit an examination of phenotypic changes that are associated with changes in the synthesis of a particular protein. As well, studies using inducible expression in stable cell lines overcome some of the inherent limitations of transient transfection studies, including variable transfection efficiencies and the undesirable physiological effects of the transfection reagents. However, with most regulated expression systems, inactivation is usually not complete, and, as well, the inducers (i.e., heat shock, metal ions and hormones) often activate endogenous promoters or affect other cellular processes. An alternative approach is to use prokaryotic promoters and their activators, such as the tetracycline-regulated gene expression system that uses elements from the E. colitetracyclineresistance operon (9) . The tetracycline repressor is converted into a transcriptional activator (trans-activator protein [tTA] ) by the addition of the activation domain of the herpes simplex virus protein VP16 (9) . This transactivator can stimulate transcription from a promoter containing tetracycline operator sequences ( tetO), but is prevented from interacting with the tetOby micromolar concentrations of tetracycline. This system allows high levels of expression in the activated state and essentially complete inactivation at tetracycline concentrations that are not toxic for eukaryotic cells (reviewed in Reference 8) .
Establishing an optimal tTA-controllable system, i.e., tight regulation and large activation factors, requires sequential transfection and screening steps that can take several months to complete (3, 4) . Initially, a target cell line expressing tTA must be established and characterized. Stable clones expressing tTA are commonly screened by transient transfection with plasmids encoding either luciferase or β -galactosidase linked to tTA-responsive promoters. The tTA-expressing cell line can then be used to establish stable cell lines expressing a gene of interest. In situations in which the gene product interferes with cell growth or survival, the transfection and selection must be carried out in media containing tetracycline at a level that has been predetermined to be sufficient to prevent tTAregulated expression. Isolated clones must be screened for their ability to express the gene product at a high level, and in a regulated manner, by comparing expression in the presence and absence of tetracycline. Generally, this is accomplished by measuring the relative abundance of the expressed protein by either Western blotting or immunofluorescence analysis.
Clearly, the usefulness of this system would be greatly increased by improved methods for the screening and selection of tTA-expressing cell lines (18) . For this reason we have generated response plasmids encoding the green fluorescent protein (GFP) from the jellyfish Aequorea victoria (14) placed under the control of the tTA-responsive promoter. GFP fluorescence is an inherent property of the protein and thus, unlike other reporter proteins, such as luciferase or β -galactosidase, no cofactors or exogenous substrates are required (reviewed in Reference 2). As such, GFP fluorescence can be readily and noninvasively detected in living cells. The fluorescent properties of the protein are similar to that of fluorescein and can be visualized with a standard fluorescence microscope. In addition, cells expressing the GFP can be selected and sorted using a fluorescence-activated cell sorter (17) . GFP has been expressed, without cytotoxic effects, in a wide range of organisms and has great potential as a marker for monitoring cell lineage and gene expression (reviewed in Reference 2). We have used this tTA-controllable GFP reporter construct to select tTA-expressing cells out of a mixed population. Furthermore, to ease the process of screening cells expressing a tTA-controllable gene of interest, we have constructed a dicistronic expressor-reporter cassette. Incorporation of the encephalomyocarditis virus internal ribosome entry site (IRES) into the plasmid encoding GFP makes it possible to express a dicistronic mRNA encoding both the GFP and a protein of interest. With this response plasmid it is possible to identify stable clones containing a tTA-regulatable gene of interest by simply identifying, with an inverted fluorescent microscope, those cells that express GFP. Since the level of GFP is proportional to that of the coexpressed protein, this method eliminates the need to characterize levels of the target protein when screening clones.
MATERIALS AND METHODS

Construction of Response Plasmids
The plasmid pTR/GFP (tetracycline regulatable) contains the gene encoding the S65T mutant GFP protein under the control of the tTA-activated promoter. Initially, a response plasmid encoding wild-type GFP was constructed by inserting the Kpn I-BamHI fragment containing the wild-type GFP sequence from TU#65 (1) into Ksp I-BamHI-cut pUHD10.3, which contains the tTA-responsive promoter (16) . The Kpn I and Ksp I sites were made blunt with Klenow before ligation. Subsequently, an Nco I-BamHI fragment from this plasmid, containing sequences encoding from amino acid 56 to the termination codon, was replaced with an Nco IBamHI fragment from pRSET-S65T containing the serine 65 to threonine mutation (11) . This S65T mutant GFP protein is about sixfold brighter than the wild-type GFP protein (11) . All restriction and DNA-modifying enzymes were purchased from New England Biolabs (Beverly, MA, USA).
The pTR-DC/GFP plasmid (DC = dicistronic) was constructed by first inserting an Eco RI-BamHI fragment from the plasmid BSICZSVPA (7), which contains the encephalomyocarditis virus IRES and sequences encoding the first 38 amino acids of the chloramphenicol acetyltransferase protein, into Eco RI-Bam HI-cut pUHD10.3. A BamHI fragment containing the coding sequence of the S65T mutant GFP protein from the plasmid pRSET-S65T (11) was then inserted, in frame, into the BamHI site of the pTR-DC plasmid.
A tTA-regulatable c-myc ∆ 106-143 expression cassette (pTR/c-myc ∆ ) was created by inserting the Dra III-Eco RI fragment containing human c-mycgenomic DNA, from pDOR-c-myc ∆ 106-143 (19) , into pUHD10.3 cut with Ksp I and Eco RI. The c-mycgenomic DNA insert encompasses exons II and III and contains an internal deletion, removing sequences coding for amino acids 106-143 (19) . The Dra III and Ksp I ends were made blunt before ligation. To assemble a tTA-regulatable dicistronic expression cassette encoding both c-myc ∆ and GFP (pTR-DC/cmyc ∆ ,GFP), an Aat II-Ksp I fragment from pTR-DC/GFP, containing the tetO/promoter, was replaced with an Aat II-Eco RI fragment from pTR/cmyc ∆ , containing the tetO/promoter and c-myc ∆coding sequences. The Ksp I and Eco RI ends were made blunt before ligation.
Cell Culture and Transfection
The human acute lymphoblastic leukemia cell line, PEER (15) , was cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS; Life Technologies, Gaithersburg, MD, USA). The PEER cells were transfected by electroporating 10 µ g of plasmid DNA using a Bio-Rad Gene Pulser ® (Hercules, CA, USA). Plasmid DNA for transfection was purified using QIAGEN plasmid kits (Chatsworth, CA, USA). Cells (1 ×10 7 in 0.4 mL complete media) were exposed to an electric pulse of 230 V with a capacitance of 960 µ F at room temperature. For the establishment of a stable pool of PEER cells expressing tTA, cells were transfected with the plasmid ptTA-hygro and selected for growth in media containing hygromycin (Sigma Chemical, St. Louis, MO, USA) at a concentration of 200 µ g/mL. The ptTAhygro plasmid was created by inserting a fragment containing the hygromycinresistance gene from pCEP4 (Invitrogen, San Diego, CA, USA) into the plasmid pUHD15.1 encoding tTA (9) . The human kidney cell line 293S (provided by Michael Matthew, Cold Spring Harbor, NY, USA) and a derivative expressing tTA, 293-tTA (to be described elsewhere), were maintained in Dulbecco's modified Eagle medium (DMEM) with 10% FBS. Transfection of 293 cells was carried out by calcium phosphate precipitation using 10 µ g of purified DNA. Reporter gene expression was examined in transiently transfected PEER-tTA and 293-tTA cells incubated with the tetracycline derivative anhydrotetracycline (Spectrum Chemical, Gardena, CA, USA). Luciferase activities were measured in extracts of PEER-tTA cells transfected with the plasmid pUHC13.3 containing a tTAresponsive luciferase gene (9) . The luciferase assays were carried out using the Promega luciferase assay system (Madison, WI, USA) and quantitated in a Berthold Lumat LB9501 luminometer (Berthold Systems, Pittsburgh, PA, USA).
Flow Cytometry Analysis and Cell Sorting
Flow cytometric analyses were performed using an EPICS ® Profile II (Coulter, Hialeah, FL, USA) equipped with a 15-mW argon-ion laser. Cell sorting was carried out on an EPICS V (Model 752; Coulter) multiparameter laser flow cytometer and cell sorter, using the AUTO-CLONE ™ (multiwell automated cell deposition system). Laserexcitation was 500 mW at 488 nm using a 2-W argon-ion laser (Coherent, Palo Alto, CA, USA). All data collection was done using the Multiparameter Data Acquisition and Display System (MDADS; Coulter). On both instruments, the emission of the GFPS65T protein was measured using the following combination of filters: 488-nm laser-blocking, 550-nm long-pass dichroic and 525-nm band-pass. For dead cell discrimination and cell cycle analysis, a 590-nm long-pass filter for the emission of propidium iodide (Sigma Chemical) was used. Optical filters were purchased from Coulter or Omega Optical (Brattleboro, VT, USA).
For the analysis of GFP expression, the cells were collected and concentrated (1 ×10 6 cells/mL) in phosphatebuffered saline (PBS) prior to flow cytometry. PEER-tTA cells, transiently transfected with the plasmid pTR/GFP, were sorted by gating fluorescent cells under sterile conditions. Prior to sorting, the cells were concentrated (5 × 10 6 cells/mL) in complete medium buffered with HEPES (Life Technologies) at pH 7.0 and containing propidium iodide at a concentration of 5 µ g/mL in order to stain and discriminate dead cells. Immediately before sorting, the cell suspension was filtered through a sterile 60-µ m nylon mesh to remove cell clumps. The most highly fluorescent cells, representing 5% of the viable cell population, were gated and collected into a 96-well dish at a concentration of 100 cells/well.
Cell cycle distribution was assessed in 293-tTA cells transiently transfected with either the pTR/GFP or the dicistronic pTR-DC/c-myc ∆ -GFP plasmids by measuring the DNA content of propidium iodide-stained cells. The cells were washed twice with PBS (1000 rpm, 10 min) and then fixed with 1% paraformaldehyde (Fisher Scientific, Pittsburgh, PA, USA) for 1 h on ice. Fixation with paraformaldehyde, rather than ethanol, was necessary to preserve GFP fluorescence. After fixation, the samples were washed, resuspended in PBS and kept at 4°C overnight. To stain DNA, the fixed cells (1 ×10 6 cells in 400 µ L PBS) were incubated for 15 min at 37°C with 100 µ L of 5 mg/mL RNase (Sigma Chemical), followed by incubation at room temperature in the dark with 50 µ L of 1 mg/mL propidium iodide. The data were saved in List Mode File and reanalyzed using ELITE software (Coulter). The DNA content profiles were quantified for cell cycle phases using the Multicycle software (Phoenix Flow System, San Diego, CA, USA). Debris, doublets and aggregates were gated out using a bit map surrounding the population. The analysis was also performed on separately gated populations of GFP-positive and GFPnegative cells.
Western Blotting
Levels of the c-Myc protein in cells transfected with either the pTR/c-myc ∆ or the dicistronic pTR-DC/c-myc ∆ -GFP plasmids were assessed by Western blotting. Following transfection (48 h post-transfection), the cells were washed with PBS, centrifuged and frozen at -80°C. The pellets were resuspended in lysis buffer (97 mM Tris-HCl [pH 6.9], 10% glycerol, 2% SDS) and then sonicated to disrupt high molecular weight DNA. Total protein was quantitated in the lysates using the DC Protein Assay Kit (Bio-Rad). Prior to electrophoresis, the samples were mixed with an equal volume of 2 × Trisglycine SDS sample buffer (Novex, San Diego, CA, USA) and heated at 95°C for 5 min. Samples containing equivalent amounts of protein (30 µ g) were loaded onto 10% acrylamide Trisglycine gels (Novex). Following electrophoresis, the proteins were transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH, USA) using a Bio-Rad Mini-TransBlot apparatus. The transfer buffer consisted of 25 mM Tris-HCl (pH 8. detected using the ECL ™chemilumi -nescent detection kit (Amersham) followed by exposure to Kodak XAR-5 film (Eastman Kodak, Rochester, NY, USA).
RESULTS
Selection of Cells Expressing tTA
In an attempt to eliminate the timeconsuming process of screening individual clones by transient transfection, we developed a procedure that allows for the direct selection of tTA-expressing cells out of a mixed population ( Figure 1) . As an example, we have used this procedure to obtain a human acute lymphoblastic leukemia T-cell line (PEER) expressing tTA. The initial step involved transfecting the target cell line with the plasmid ptTA-hygro, which encodes the tTA gene and the hygromycin resistance gene. A pool of hygromycin-resistant cells was obtained by growing the transfected cells in the presence of 200 µ g/mL hygromycin for a period of 3 weeks. This dose was found to be sufficient to kill the parental cell line in 7 days. The pool of hygromycin-resistant cells was subsequently transfected with the plasmid containing the GFP gene linked to the tTA-responsive promoter (pTR/ GFP). Figure 2A shows flow cytometric profiles of the parental cell line and the hygromycin-resistant pool of ptTAhygro-transfected cells examined 24 h after transfection with the pTR/GFP plasmid. A low level of GFP expression can be seen in the pTR/ GFP-transfected parental cell line, which results from transcription initiated from the minimal promoter. The transfected hygromycinresistant pool contains a population of cells with levels of GFP expression greater than the transfected parental cell line. This population represents those transfected cells that express tTA. The range in GFP expression levels within this population is a function of several factors including cellular differences in tTA protein levels and transfection efficiency. The GFP-negative population contains tTA-expressing cells that did not take up the pTR/GFP plasmid, as well as cells that either do not express tTA or contain levels of the protein that are inadequate for transactivation.
Cells containing high levels of tTA were selected by sorting the 5% most fluorescent cells into separate wells of a 96-well dish at a concentration of 100 cells/well. Cells from six of these wells were selected at random and expanded. Each of these PEER-tTA cell lines were found to express GFP at a higher level than that of the original pool when transiently transfected with the pTR/GFP plasmid. The percentage of cells with detectable GFP expression in the pool was 18%, whereas in the six selected cell lines this value was increased to 29± 5% (range 21%-36%). This demonstrates that sorting the most fluorescent cells selected for those cells with relatively higher levels of tTA. To ensure that the tTA-mediated transactivation was regulated by tetracycline, PEER-tTA cells were transfected with both the pTR/GFP plasmid and the plasmid coding for the reporter enzyme luciferase linked to the tTA-responsive promoter (pUHC13.3). The transfected cells were allowed to recover for 5 h after electroporation, and then anhydro - 
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tetracycline was added at concentrations ranging from 0.05 to 1 ng/mL. This tetracycline derivative is more effective than tetracycline in inactivating tTA activity (10) . GFP fluorescence was measured in live cells by flow cytometry, and luciferase activity was measured in cell extracts 48 h after transfection ( Figure 2B ). Maximal inactivation of both GFP and luciferase expression was achieved in the presence of ≥ 0.5 ng/mL anhydrotetracycline. This shows that GFP expression can be used as an alternative to luciferase as a reporter for monitoring tTA-dependent transactivation potential.
Identification of Cells Expressing tTA-Regulated Gene Products
To simplify the process of identifying cells that express a tTA-inducible gene product, we constructed a dicistronic expression cassette containing both a gene of interest and the GFP gene ( Figure 1 ). The coexpression of both proteins from a single mRNA transcript was accomplished by the inclusion of the encephalomyocarditis virus IRES sequence (7). The dicistronic response plasmid that we have assembled to test our vector contains human c-mycgenomic DNA encompassing exons II and III, and containing an internal deletion corresponding to amino acids 106-143 (19) as the 5 ′ cistron and GFP as the 3 ′ cistron (pTR-DC/c-myc ∆ -GFP). A response plasmid coding for c-myc ∆linked to the tTA-responsive promoter but lacking the IRES-GFP sequences was also constructed (pTR/c-myc ∆ ).
The expression of GFP and c-myc ∆ was examined in 293-tTA cells transiently transfected with the response plasmids coding for either GFP, c-myc ∆ or the dicistronic plasmid, which coexpresses both genes ( Figure 3A) . A population of GFP-expressing cells was clearly evident by flow cytometric analysis of cells transfected with either the pTR/GFP plasmid or the dicistronic plasmid ( Figure 3A, left panel) . Western blotting revealed high levels of the c-Myc ∆protein in extracts from cells transfected with either the pTR/c -myc ∆ plasmid or the dicistronic plasmid (Figure 3A, right panel) . The level of the cMyc ∆protein in the transfected cells was severalfold above that of the endogenous c-Myc protein and could be detected in Coomassie ® blue-stained gels (data not shown).
To demonstrate that both GFP and cMyc ∆protein levels are coordinately regulated by anhydrotetracycline, 293-tTA cells were transiently transfected with the dicistronic pTR-DC/c-myc ∆ -GFP plasmid in the presence of anhydrotetracycline at concentrations ranging from 0.03 to 100 ng/mL. GFP fluorescence was measured by flow cytometry ( Figure 3B, left panel) , and cMyc ∆protein levels were quantitated by Western blotting ( Figure 3B , right panel) 48 h after transfection. GFP fluorescence in cells incubated with anhydrotetracycline is plotted as a percentage of the level measured in cells transfected in the absence of anhydrotetracycline. GFP expression was maximally inactivated at concentrations of anhydrotetracycline greater than 10 ng/mL. At these concentrations, the level of GFP fluorescence was similar to that measured in transiently transfected 293 cells that lack tTA (data not shown). The anhydrotetracycline dose response for GFP 156BioTechniques
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fluorescence is similar to that of cMyc ∆protein levels. In cells incubated with ≥ 10 ng/mL anhydrotetracycline, the c-Myc ∆protein was barely detectable by immunoblotting. Intermediate levels of the protein were evident in the cells when incubated with 3 ng/mL anhydrotetracycline; and at concentrations ≤ 1 ng/mL, synthesis of c-Myc ∆ was near maximal.
Analysis of Gene Product Function Specifically in the Expressing Cells Within a Mixed Population of Transiently Transfected Cells
In addition to the obvious utility of the dicistronic GFP plasmid for identifying clones that stably express a tTAregulated gene product, this procedure also makes it possible to identify those cells that express a protein of interest following a transient transfection. This might allow some cellular response to be measured specifically in the transfected cells rather than in the mixed population of transfected and nontransfected cells. To demonstrate this, we have examined the effect of expressing the dominant negative c-Myc mutant protein (c-Myc ∆ 106-143) on cell cycle distribution. Deletion of this domain inhibits the ability of normal c-Myc to cooperate with a mutant ras gene in the cotransformation of normal rat embryo cells (19) . Flow cytometric DNA histograms for 293-tTA cells transfected with the dicistronic construct encoding both c-Myc ∆ 106-143 and GFP revealed only minor differences in cell cycle distribution relative to cells transfected with the pTR/GFP plasmid when the analysis was carried out on the total cell population ( 
DISCUSSION
One of the most fundamental methods for studying protein function involves the expression of cloned genes in homogeneous populations of cultured cells. A major limitation of this technology is the immense time and effort involved in the generation and screening of stable cell lines expressing a protein of interest. Expression constructs that permit the co-expression of a reporter gene can facilitate the screening process by eliminating the need to measure protein levels by Western blotting. Desirable clones can be simultaneously screened and selected if the activity of the reporter protein can be measured in live cells. Cell-screening strategies have been developed using the co-expression of exogenous enzymes or cell-surface markers that are not present on the cells of interest. By co-expression of a secreted alkalinephosphatase (SEAP) protein, desired clones, growing as individual colonies on a petri dish, could be identified by placing a nylon membrane on top of an agarose overlay, to allow adsorption of the SEAP, followed by enzymatic detection (12) . Methods that permit the selection of stable transformants by fluorescence-activated cell sorting are desirable because they allow real-time analysis and isolation of positive cells. A method based on the co-expression of the E. coli β -gal enzyme (FACS-Gal) allows flow cytometric sorting of live cells (13) . However, a hypotonic treatment is required to preload the cells with the fluorogenic substrate, and the activity must be inhibited after a specific period of time before sorting. Use of the green fluorescent protein as a reporter has the advantage of allowing real-time analysis and sorting of live cells without the requirement of additional substrates or cofactors.
The use of a dicistronic expression construct that permits the co-expression of a gene of interest together with GFP eliminates the need to screen clones by assaying for the presence of the gene p roduct. This method, therefore, greatly simplifies the task of clone identification and selection. As well, it makes it possible to isolate stable cell lines expressing an uncharacterized protein for which specific antibodies do not exist. With the aid of an inverted fluorescent microscope, isolated clones growing as individual colonies can be easily identified by the presence of "green" cells. Alternatively, the GFPpositive cells can be selected and cloned by using a fluorescence-activated cell sorter or micromanipulator. An additional feature of this strategy is that stable cell lines containing an integrated dicistronic GFP cassette can be easily monitored for transgene expression during the course of an experiment. Monitoring GFP fluorescence during the activation phase could serve as a simple way to estimate the activation kinetics of the co-expressed protein. As well, measuring GFP fluorescence could be used as a simple test to ensure that expression persists in a clone after long-term cultivation or to monitor the homogeneity of the cell population.
Optimal results with the tTA system have been obtained by first establishing a tTA-expressing cell line, followed by transfection with an expressor construct. Using a well-characterized tTAexpressing host ensures optimal regulatory properties and allows comparisons among lines transfected with different expressor gene constructs. Since the level of expression of the transactivator that can be tolerated by the cell is too low to be detected adequately by immunoblotting or band shift analysis, screening for tTA expression must be carried out by a functional assay (9) . This is generally accomplished by transiently transfecting isolated clones with a tTA-regulatable reporter construct encoding either luciferase or β -galactosidase. This is a rather labor-intensive process and, not surprisingly, only a few tTA-expressing cell lines have been reported. Alternatively, cells expressing high levels of functional tTA can be selected out of a mixed population by transient transfection with the pTR/ GFP plasmid followed by fluorescent cell sorting. We have used this procedure to isolate a human lymphoblastic leukemia T-cell line expressing tTA. Efficient transfection of this, and most lymphoid cells, is best carried out by electroporation, and this requires large numbers of cells and relatively large quantities of plasmid DNA. Screening many individual clones by transient transfection is therefore a formidable task, especially when the frequency of stable integration is rare. The ability to specifically isolate cells expressing functional tTA out of a mixed population using a flow cytometer greatly simplifies the screening process.
The plasmid pTR/GFP is also potentially useful for characterizing a selected tTA-expressing clone. The dose of tetracycline necessary to completely suppress tTA activity should be determined before a tTA-expressing clone is used as a host for stable transfection with a response plasmid. This is especially important if the gene product is suspected of interfering with cell growth or survival, in which case the transfection and selection steps must be carried out in the presence of an appropriate amount of tetracycline. Measuring GFP levels in cells incubated with various concentrations of anhydrotetracycline gave nearly identical results as that obtained using luciferase as a reporter for tTA activity; however, measuring GFP is much quicker since it simply requires assaying fluorescence in live cells with a flow cytometer.
Establishing a cell line that inducibly expresses a gene of interest in response to tTA requires screening transfected clones for levels of the gene product. For each clone this analysis must be carried out on cells that have been cultured in the presence or absence of tetracycline. Ideally, a large number of clones should be screened because the degree of inducibility can vary. Activation factors ranging from 10-fold to 10 5 -fold have been reported (3, 4, 9) . Low-level expression of the transgene in the presence of tetracycline can occur in some clones as a consequence of the integration site. Screening for tetracycline-regulated expression of GFP in stable cell lines transfected with the pTR-DC/GFP plasmid greatly simplifies the task of cell screening. As well, this method eliminates the need to epitope-tag the protein of interest, which can potentially compromise the protein's function.
Since GFP fluorescence can be detected in individual cells, it should be possible to assess some parameter associated with the level of a co-expressed protein in a mixed population of cells that have been transiently transfected with the dicistronic plasmid encoding GFP. For example, by using multi-parameter flow cytometry, properties such as cell cycle distribution, ion fluxes, phagocytosis or surface protein expression could be analyzed specifically within the population of "green" cells. We have used this approach to demonstrate an effect of expressing a dominant negative c-Myc protein on cell cycle distribution in transiently transfected 293-tTA cells. Since the level of the co-expressed protein is proportional to the level of GFP fluorescence, it should also be possible to correlate phenotypic changes associated with different levels of expression by restricting the analysis to subpopulations of cells having different levels of GFP fluorescence. The tetracycline-regulatable system has recently been applied to control gene expression in transgenic plants (20) and animals (6) and undoubtedly will find applications in gene therapy. Using a dicistronic cassette encoding GFP could also aid in assessing transgene expression in vivo, which is an essential parameter for the success of gene therapy protocols.
Note added in proof:During the period between acceptance of this paper and the receipt of proofs, we have used the method that we have described to obtain 6 additional cell lines expressing the tetracycline-regulated transactivator protein and cell lines expressing either c-Myc ∆ or hsp70 together with GFP using the tTA-regulated dicistronic expression cassette.
